BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Aug. 4, 2004
View Archived Issues
Zeltia Subsidiary Neuropharma Brings In EUR16M For Alzheimer's
Neuropharma SA, a subsidiary of Zeltia Group, raised €16 million in its first external funding round to progress several preclinical programs in Alzheimer's disease. (BioWorld International)
Read More
Gearing Up To Crack Down On Animal Terrorism' In UK
Read More
Researchers: Genome Sequence To Hasten New Acne Therapies
Read More
EU Looking Ahead To Better Conditions For Biotech Sector
Read More
Ireland Moving To Strengthen Biomanufacturing Capabilities
Read More
Other News To Note
Read More